RUNBEN BIOTECHNOLOGY (603193.SS)

CNY 35.25

(3.68%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019
Total Assets 2.01 Billion 825.42 Million 646.33 Million 276.46 Million 164.42 Million
Total Current Assets 1.71 Billion 510.04 Million 344.35 Million 141.81 Million 73.8 Million
Cash And Short Term Investments 262.82 Million 376.45 Million 262.42 Million 81.7 Million 35.4 Million
Cash and Cash Equivalents 243.82 Million 368.21 Million 206.18 Million 39.52 Million 31.11 Million
Short Term Investments 19 Million 8.23 Million 56.23 Million 42.17 Million 4.28 Million
Net Receivables 15.42 Million 14.78 Million 15.12 Million 7.43 Million 7.08 Million
Inventory 92.91 Million 102.71 Million 56.89 Million 45.22 Million 29.57 Million
Other Current Assets 1.34 Billion 16.09 Million 9.9 Million 7.46 Million 1.72 Million
Total Non-Current Assets 302.53 Million 315.37 Million 301.98 Million 134.64 Million 90.62 Million
Net PPE 260.42 Million 277.56 Million 207.67 Million 108.72 Million 67.34 Million
Good Will And Intangible Assets 18.75 Million 19.36 Million 19.88 Million 20.54 Million 21.09 Million
Good Will - - - - -
Intangible Assets 18.75 Million 19.36 Million 19.88 Million 20.54 Million 21.09 Million
Long-Term Investments 1.41 Million 2.00 - - 1.00
Tax Assets 20.81 Million 14.79 Million 5.66 Million 2.38 Million 2.06 Million
Other Non Current Assets 1.12 Million 3.65 Million 68.76 Million 2.98 Million 121.65 Thousand
Other Assets - - 1.00 - -
Total Liabilities 97.61 Million 102.83 Million 84.69 Million 26.32 Million 27.07 Million
Total Current Liabilities 95.12 Million 96.59 Million 75.51 Million 24.22 Million 25.28 Million
Account Payables 52.71 Million 47.63 Million 46.37 Million 13.26 Million 14.17 Million
Tax Payables 19.25 Million 28.87 Million 9.38 Million 1.55 Million 1.18 Million
Short Term Debt 1.95 Million 2.51 Million 2.4 Million -3.43 Million -
Deferred Revenue 39.61 Million 45.69 Million 25.54 Million 3.43 Million -
Other Current Liabilities 842.18 Thousand 758.08 Thousand 1.19 Million 10.96 Million 11.11 Million
Total Non Current Liabilities 2.48 Million 6.23 Million 9.17 Million 2.1 Million 1.78 Million
Long-Term Debt 2.04 Million 5.39 Million 7.9 Million - -
Deferred Revenue Non Current 11.21 Thousand 271.5 Thousand 1.12 Million 2.04 Million 1.78 Million
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities 2.00 1.00 1.00 - -
Other Liabilities -0.00 1.00 - 1.00 1.00
Total Equity 1.92 Billion 722.58 Million 561.64 Million 250.13 Million 137.35 Million
Stock Holders Equity 1.92 Billion 722.58 Million 561.64 Million 250.13 Million 137.35 Million
Common Stock 404.59 Million 343.9 Million 343.9 Million 103.07 Million 60 Million
Retained Earnings 453.16 Million 240.46 Million 94.7 Million 20.59 Million 66.91 Million
Accumulated other comprehensive income 54.02 Million 138.21 Million 123.03 Million 126.46 Million -
Common Stock Equity 1.92 Billion 722.58 Million 561.64 Million 250.13 Million 137.35 Million
Capital Lease Obligation 2.04 Million 5.39 Million 7.9 Million - -
Total Investments 19 Million 8.23 Million 56.23 Million 42.17 Million 4.28 Million
Total Debt 3.99 Million 7.9 Million 10.3 Million - -
Net Debt -239.82 Million -360.3 Million -195.87 Million -39.52 Million -31.11 Million

Balance Sheet Charts